Mealey's (October 19, 2023, 12:50 PM EDT) -- DENVER — Arguing in part that the appellees’ “proffered reasons” why the case is exceptionally important “rely on mischaracterization and unmoored rhetoric,” the Pharmaceutical Care Management Association (PCMA) has opposed en banc rehearing of an appeal in which a 10th Circuit U.S. Court of Appeals panel ruled that the Employee Retirement Income Security Act preempts four parts of an Oklahoma law pertaining to pharmaceutical benefit managers (PBMs)....